Clinical Trials Directory
The purpose of this study is to see how a treatment called TMS can help people move their arms better. TMS stands for transcranial magnetic stimulation. It uses magnets to help the brain work in a different way. TMS is already approved to help people with depression, and doctors have also looked at how it helps people after a stroke. But scientists still need to learn the best way to use it to help people recover.
If you join this study, you will have the surgery your doctor planned. You can choose to use the regular tool or be randomly picked to use either the regular tool or a new one. Blood will be taken three times (before, during, and after surgery). Doctors will also check your regular cancer visits for one year. The study does not add extra visits or tests.
This study looks at different treatments for early breast cancer (DCIS). It has four parts: - Screening: Doctors do tests to see if you can join. - Treatment: You’re randomly placed in a group to get either standard medicine or a new treatment. - Surgery Check: After 3 months, doctors decide if surgery is needed. - Follow-Up: You’ll get check-ups for up to 5 years, and yearly follow-ups for 10 years. Treatments may include pills, hormone therapy, or small pellets under the skin. You’ll also have tests like MRIs, mammograms, and blood samples.
This study is testing a special device called the BioVentrix Revivent System to help people with heart failure. Some people in the study will get this device along with regular heart medicine, and others will get only the regular medicine. Doctors want to see which treatment works better. The device is used to treat damaged areas of the heart, especially in the front and bottom parts. These damaged areas are called scars or aneurysms. The goal is to help the heart work better and make people feel healthier. Doctors will check how safe the device is and how well it helps the heart over time. People in the study will be watched closely and have regular check-ups.
We are doing this study to find out if an experimental drug called RP2 (the study drug) is a safe and effective option for people who have uveal melanoma (melanoma in the eye). We want to know how well the study drug works when it is combined with a drug called nivolumab, and we will compare its outcomes to treatment with the drug combination of nivolumab + ipilimumab.